Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Saad Ibrahim

Diagnostic Radiology Fort Wayne, IN Medical Doctor

NPI 1578885315 CMS profile 1281798

7950 W Jefferson Blvd, Fort Wayne, IN 46804

Open in the dashboard

General payments

$13,323

181 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Saad Ibrahim of Fort Wayne, IN is reported in the CMS Open Payments database as having received $13,323 across 181 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,235 23
2024 General $1,226 25
2023 General $3,385 35
2022 General $2,053 36
2021 General $2,568 29
2020 General $667 9
2019 General $2,190 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Saad Ibrahim
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Saad Ibrahim were reported at $1,235. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Saad Ibrahim Diagnostic Radiology median Middle half National median
2019 $2,190 $108 $29–$318 $163
2020 $667 $65 $21–$252 $114
2021 $2,568 $92 $24–$292 $132
2022 $2,053 $104 $29–$294 $149
2023 $3,385 $110 $29–$337 $160
2024 $1,226 $113 $30–$356 $164
2025 $1,235 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $4,100 34 payments
  2. Boston Scientific Corporation $2,537 26 payments
  3. Medtronic, Inc. $2,196 52 payments
  4. Medtronic USA, Inc. $1,022 10 payments
  5. Shockwave Medical, Inc $819 23 payments
  6. AngioDynamics, Inc. $566 7 payments
  7. Philips Electronics North America Corporation $455 3 payments
  8. Bard Peripheral Vascular, Inc. $422 9 payments
  9. Medtronic Vascular, Inc. $298 4 payments
  10. W. L. Gore & Associates, Inc. $251 2 payments
  11. Other $657 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,721 174 payments
  2. Travel and Lodging $1,969 5 payments
  3. Long term medical supply or device loan $333 1 payment
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $300 1 payment
Products named General payments · program years 2019–2025
  1. Indigo System $3,417 24 payments
  2. KYPHON Balloon Kyphoplasty Neuro Pain (includes Interventional) $1,022 10 payments
  3. Abre $744 25 payments
  4. General Therapies $682 4 payments
  5. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Lithoplasty $497 13 payments
  6. KYPHON EXPRESS II KYPHOPAK TRAY $477 5 payments
  7. Auryon Laser System 100-120 Vac $333 1 payment
  8. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Cardiology $322 10 payments
  9. KYPHON Balloon Kyphoplasty Neuro Pain (includes Interventional) $313 3 payments
  10. Spectranetics Undiv $300 1 payment
  11. Other $5,013 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for Diagnostic Radiology: 24

Drug cost

$83

Median for Diagnostic Radiology: $190

Branded share of claims

100%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 14 $83

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 158 billing codes

Paid by Medicare

$88,605

Medicare's payments for the services billed

Medicare patients

758

Average age 73

Services billed

1,307

376 women, 382 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Diabetes 43%
Ischemic heart disease 42%
Chronic kidney disease 34%
COPD 31%
Heart failure 29%
Atrial fibrillation 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

181 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record